CATH Superfamily 2.60.120.970
The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 19: Transforming growth factor beta-3
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 9 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
10 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NAV5 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT41 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) Q4R461 (/ISS) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
9 | F6Q651 (/ISS) G1NAV5 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT41 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) Q4R461 (/ISS) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
7 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
7 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) |
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
|
7 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) |
Amyloid-beta binding GO:0001540
Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Transforming growth factor beta receptor binding GO:0005160
Interacting selectively and non-covalently with the transforming growth factor beta receptor.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
There are 54 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
10 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NAV5 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT41 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) Q4R461 (/ISS) |
Salivary gland morphogenesis GO:0007435
The process in which the anatomical structures of the salivary gland are generated and organized.
|
10 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NAV5 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT41 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) Q4R461 (/ISS) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
10 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NAV5 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT41 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) Q4R461 (/ISS) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
10 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NAV5 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT41 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) Q4R461 (/ISS) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
10 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NAV5 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT41 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) Q4R461 (/ISS) |
Negative regulation of macrophage cytokine production GO:0010936
Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
10 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NAV5 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT41 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) Q4R461 (/ISS) |
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
|
10 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NAV5 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT41 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) Q4R461 (/ISS) |
Cell-cell junction organization GO:0045216
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.
|
10 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NAV5 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT41 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) Q4R461 (/ISS) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
7 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
7 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
7 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) |
Ossification involved in bone remodeling GO:0043932
The formation or growth of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone, involved in response to injury or other physical, physiological or environmental stress stimuli.
|
7 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
7 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) |
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
|
7 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) |
Detection of hypoxia GO:0070483
The series of events in which a stimulus indicating lowered oxygen tension is received by a cell and converted into a molecular signal. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
7 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) |
Cell morphogenesis GO:0000902
The developmental process in which the size or shape of a cell is generated and organized.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Eye development GO:0001654
The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Cell cycle arrest GO:0007050
A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Cell death GO:0008219
Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538).
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Glial cell migration GO:0008347
The orderly movement of a glial cell, non-neuronal cells that provide support and nutrition, maintain homeostasis, form myelin, and participate in signal transmission in the nervous system.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Response to wounding GO:0009611
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Cardioblast differentiation GO:0010002
The process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Positive regulation of epithelial cell migration GO:0010634
Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Negative regulation of alkaline phosphatase activity GO:0010693
Any process that decreases the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Signal transduction by protein phosphorylation GO:0023014
A process in which the transfer of one or more phosphate groups to a substrate transmits a signal to the phosphorylated substrate.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Activation of protein kinase activity GO:0032147
Any process that initiates the activity of an inactive protein kinase.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Positive regulation of stress-activated MAPK cascade GO:0032874
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Regulation of transforming growth factor beta2 production GO:0032909
Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Positive regulation of cell adhesion mediated by integrin GO:0033630
Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Positive regulation of integrin biosynthetic process GO:0045726
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of integrins.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Positive regulation of ossification GO:0045778
Any process that activates or increases the frequency, rate or extent of ossification, the formation of bone or of a bony substance or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Positive regulation of heart contraction GO:0045823
Any process that activates or increases the frequency, rate or extent of heart contraction.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Embryonic digestive tract development GO:0048566
The process whose specific outcome is the progression of the gut over time, from its formation to the mature structure during embryonic development. The gut is the region of the digestive tract extending from the beginning of the intestines to the anus.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Positive regulation of timing of catagen GO:0051795
Any process that activates or increases the frequency, rate or extent of timing of catagen, the regression phase of the hair cycle.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Positive regulation of cardioblast differentiation GO:0051891
Any process that activates or increases the frequency, rate or extent of cardioblast differentiation, the process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Cardiac muscle cell proliferation GO:0060038
The expansion of a cardiac muscle cell population by cell division.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Pathway-restricted SMAD protein phosphorylation GO:0060389
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Hair follicle development GO:0001942
The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open.
|
2 | G9KT41 (/ISS) Q4R461 (/ISS) |
There are 3 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
|
10 | A0A087R4W7 (/ISS) F6Q651 (/ISS) G1NAV5 (/ISS) G1NJH0 (/ISS) G1T192 (/ISS) G9KT41 (/ISS) G9KT42 (/ISS) H0ZPS5 (/ISS) H0ZPS5 (/ISS) Q4R461 (/ISS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
3 | G1NAV5 (/ISS) G9KT41 (/ISS) Q4R461 (/ISS) |